BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 17664233)

  • 1. Monoclonal gammopathy in systemic lupus erythematosus.
    Ali YM; Urowitz MB; Ibanez D; Gladman DD
    Lupus; 2007; 16(6):426-9. PubMed ID: 17664233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgM monoclonal gammopathy in plasmacytic neoplasms].
    Kraj M; Kopeć I; Rostkowska J; Pogłód R; Maj S
    Acta Haematol Pol; 1990; 21(2):153-65. PubMed ID: 2131715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurological manifestations of monoclonal gammopathies].
    Chassande B; Léger JM
    Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy in atomic bomb survivors.
    Neriishi K; Yoshimoto Y; Carter RL; Matsuo T; Ichimaru M; Mikami M; Abe T; Fujimura K; Kuramoto A
    Radiat Res; 1993 Mar; 133(3):351-9. PubMed ID: 8451386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.
    Verroust P; Mery JP; Morel-Maroger L; Clauvel JP; Richet G; Bouteiller AM; Fumagalli N
    Adv Nephrol Necker Hosp; 1971; 1():161-94. PubMed ID: 4377644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy in a tertiary referral hospital.
    Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
    Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma and systemic lupus erythematosus in a young woman.
    Okoli K; Irani F; Horvath W
    J Clin Rheumatol; 2009 Sep; 15(6):292-4. PubMed ID: 19734735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].
    Ruiz-Delgado GJ; Gómez Rangel JD
    Gac Med Mex; 2004; 140(4):375-9. PubMed ID: 15456147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of monoclonal gammopathy among patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Pereira D; Sussman G; Gladman DD
    J Rheumatol; 2012 Mar; 39(3):564-7. PubMed ID: 22247355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors.
    Urowitz MB; Ibañez D; Gladman DD
    J Rheumatol; 2007 Jan; 34(1):70-5. PubMed ID: 17117488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.